Xtract One Announces Terms of Public Offering and Concurrent Investment by Strategic Partner
Xtract One Announces Terms of Public Offering and Concurrent Investment by Strategic Partner
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.
本新聞稿僅在加拿大發行,不打算分發給美國新聞通訊社或在美國傳播。
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Xtract One Technologies Inc. (TSX: XTRA) (OTCQX: XTRAF) (FRA: 0PL) ("Xtract One" or the "Company") is pleased to announce that it has priced its previously announced public offering (the "Offering"). The Offering is being conducted by Eight Capital, as lead agent and sole bookrunner, and Echelon Wealth Partners Inc. (together with Eight Capital, the "Agents") pursuant to which the Agents have agreed to conduct the Offering on a commercially reasonable best efforts basis.
多倫多,2024年4月18日(環球通訊社)——Xtract One Technologies Inc.(多倫多證券交易所股票代碼:XTRA)(場外交易所股票代碼:XTRAF)(FRA:0PL)(“Xtract One” 或 “公司”)高興地宣佈,它已經對先前宣佈的公開募股(“本次發行”)進行了定價。本次發行由作爲牽頭代理人和唯一賬簿管理人的Eight Capital和Echelon Wealth Partners Inc.(以及Eight Capital,“代理人”)進行,代理商已同意在商業上合理的最大努力基礎上進行此次發行。
Pursuant to the Offering, the Company intends to issue units (each, a "Unit") at a price of $0.51 per Unit for gross proceeds of up to $5 million. Each Unit will consist of one common share of the Company (each, a "Common Share") and one common share purchase warrant (each, a "Warrant"). Each Warrant will be exercisable into one Common Share (each, a "Warrant Share") for a period of 36 months from the closing of the Offering at an exercise price of $0.64, subject to adjustment in certain events. The Offering is expected to close on or about April 24, 2024 (the "Closing Date") and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and stock exchange approvals, including the approval of the Toronto Stock Exchange (the "TSX") and the applicable securities regulatory authorities.
根據本次發行,公司打算以每單位0.51美元的價格發行單位(每個 “單位”),總收益最高爲500萬美元。每個單位將由公司的一股普通股(每股 “普通股”)和一份普通股購買權證(均爲 “認股權證”)組成。每份認股權證可行使爲一股普通股(每股 “認股權證”),期限爲自本次發行結束之日起36個月,行使價爲0.64美元,在某些情況下可能進行調整。本次發行預計將於2024年4月24日左右(“截止日期”)結束,並受某些條件的約束,包括但不限於獲得所有必要的監管和證券交易所批准,包括多倫多證券交易所(“TSX”)和適用的證券監管機構的批准。
The Company has granted the Agents an option (the "Over-Allotment Option") to increase the size of the Offering by up to 15%, exercisable in whole or in part at any time, at the sole discretion of the Agents, to acquire either (i) additional Units, (ii) additional Shares or (iii) additional Warrants, or a combination thereof, for a period of 30 days from and including the Closing Date (as defined herein).
公司已授予代理商一個期權(“超額配股期權”),將發行規模最多擴大15%,可隨時行使全部或部分行使,由代理人自行決定,在自截止日期(定義見本文所述)起30天內收購(i)額外單位、(ii)額外股份或(iii)額外認股權證,或兩者的組合。
The Units will be offered by way of a prospectus supplement to the Company's short form base shelf prospectus dated February 6, 2024 (together, the "Prospectus") to be filed in all provinces and territories of Canada, except Québec.
這些單位將以公司2024年2月6日的簡短基本架構招股說明書(合稱 “招股說明書”)的補充招股說明書的形式提供,該招股說明書將在加拿大除魁北克省以外的所有省份和地區提交。
In connection with the Offering, the Company has agreed: (i) to pay to the Agents a cash commission equal to 7.0% of the aggregate gross proceeds of the Offering (including any gross proceeds raised on exercise of the Over-Allotment Option), other than in respect of gross proceeds raised from purchasers on the Company's president's list, for which the Agents will receive a cash commission equal to 3.5%; and (ii) to issue to the Agents an aggregate number of agents' warrants (the "Agents' Warrants") equal to 7.0% of the aggregate number of Units issued pursuant to the Offering (including any Units issued on exercise of the Over-Allotment Option), other than in respect of Units sold to purchasers on the Company's president's list, for which the Agents will receive Agents' Warrants equal to 3.5%. Each Agents' Warrant will be exercisable into one Common Share (an "Agents' Warrant Share") at an exercise price of $0.51 for a period of 24 months from the Closing Date.
在本次發行中,公司同意:(i)向代理人支付相當於本次發行總收益(包括行使超額配股權籌集的任何總收益)7.0%的現金佣金,但從公司總裁名單上的買方籌集的總收益除外,代理人將獲得相當於3.5%的現金佣金;(ii)向代理人發放總數字代理人的認股權證(“代理認股權證”)等於根據以下規定發行的單位總數的7.0%本次發行(包括行使超額配股權時發行的任何單位),但向公司總裁名單上的買方出售的單位除外,代理人將獲得相當於3.5%的代理認股權證。每份代理人的認股權證均可行使爲一股普通股(“代理認股權證”),行使價爲0.51美元,爲期24個月,自截止日期起。
The Company will apply to list the Common Shares, Warrant Shares, Agents' Warrant Shares and Warrants issuable pursuant to the Offering on the TSX. Copies of the Prospectus, following filing thereof, can be obtained on the Company's SEDAR+ profile at and from the Agents by contacting ecm@viiicapital.com. The Prospectus contains important detailed information about the Company and the proposed Offering. Prospective investors should read the Prospectus and the other documents the Company has filed on SEDAR+ before making an investment decision.
公司將申請在多倫多證券交易所上市普通股、認股權證股、代理認股權證和根據本次發行可發行的認股權證。在提交招股說明書後,可以在公司的SEDAR+個人資料上獲得招股說明書的副本,也可以聯繫 ecm@viiicapital.com 從代理商處獲得。招股說明書包含有關公司和擬議發行的重要詳細信息。在做出投資決定之前,潛在投資者應閱讀招股說明書和公司在SEDAR+上提交的其他文件。
Concurrent Private Placement
同步私募配售
In addition to and concurrent with the Offering, the Company has agreed to issue and sell Units (the "PP Units"), on a private placement basis (the "Concurrent Private Placement"), to MSG Sports Ventures, LLC ("MSG Sports"), a wholly-owned subsidiary of Madison Square Garden Sports Corp. (NYSE: MSGS), in order to permit MSG Sports to maintain its pro rata interest in the outstanding securities of the Company. The final number of PP Units to be sold and amount of proceeds to be raised under the Concurrent Private Placement will be equal to approximately 19.18% of the Units sold under the Offering as well as additional Units and/or Shares (if any) pursuant to the Over-Allotment Option, if any. No finder's fees or commissions will be paid in connection with the Concurrent Private Placement.
除本次發行外,公司還同意以私募方式(“並行私募配售”)向麥迪遜廣場花園體育公司(紐約證券交易所代碼:MSG)的全資子公司MSG Sports Ventures, LLC(“MSG Sports”)發行和出售單位(“PP單位”),以允許MSG Sports維持其股份(“PP單位”) 按比例計算 本公司未償還證券的利息。擬出售的PP單位的最終數量和在同步私募下籌集的收益金額將等於本次發行下出售的單位的大約19.18%,以及根據超額配股權獲得的額外單位和/或股份(如果有)(如果有)。不會支付與同步私募相關的發現者費用或佣金。
Closing of the Concurrent Private Placement is expected to occur concurrently with the closing of the Offering and is subject to certain conditions including, but not limited to, the concurrent completion of the Offering and the receipt of all necessary regulatory approvals, including the approval of the TSX. Closing of the Offering is not conditional on the closing of the Concurrent Private Placement.
預計同步私募配售的結束將與本次發行的結束同時進行,並受某些條件的約束,包括但不限於同時完成發行和獲得所有必要的監管批准,包括多倫多證券交易所的批准。本次發行的結束不以同時私募配售的結束爲條件。
Xtract One intends to use the proceeds of the Offering and the Concurrent Private Placement for working capital and general corporate purposes.
Xtract One打算將本次發行和同步私募的收益用於營運資金和一般公司用途。
No securities regulatory authority has either approved or disapproved of the contents of this press release. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of the securities, in any jurisdiction in which such offer, solicitation or sale would be unlawful. The securities being offered have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the "1933 Act") and may not be offered or sold in the United States or to, or for the account or benefit of, U.S. persons absent registration or an applicable exemption from the registration requirements of the 1933 Act, and applicable state securities laws.
沒有任何證券監管機構批准或不批准本新聞稿的內容。在任何非法要約、招攬或出售的司法管轄區,本新聞稿不應構成賣出要約或買入要約的邀請,也不應有任何證券的出售。所發行的證券過去和將來都沒有根據經修訂的1933年《美國證券法》(“1933年法案”)進行註冊,也不得在美國發行或出售,也不得向未經註冊或未獲得1933年法和適用的州證券法註冊要求的適用豁免的美國人發行或出售,也不得爲美國人的賬戶或利益進行發行或出售。
About Xtract One
關於 Xtract One
Xtract One Technologies is a leading technology-driven threat detection and security solution leveraging AI to provide seamless and secure patron access control experiences. The Company makes unobtrusive threat detection systems that enable venue building operators to prioritize and deliver improved patron experiences while providing unprecedented safety. Xtract One's innovative Gateway product enables companies to covertly screen for weapons at points of entry without disrupting the flow of traffic. Its AI-based software allows venue and building operators to identify weapons and other threats inside and outside of facilities and receive valuable intelligence for optimizing operations. For more information, visit or connect on Facebook, Twitter, and LinkedIn.
Xtract One Technologies是領先的技術驅動的威脅檢測和安全解決方案,利用人工智能提供無縫和安全的用戶訪問控制體驗。該公司生產不顯眼的威脅檢測系統,使場館建築運營商能夠優先考慮並提供更好的顧客體驗,同時提供前所未有的安全性。Xtract One的創新Gateway產品使公司能夠在不中斷交通的情況下在入境點祕密篩選武器。其基於人工智能的軟件使場地和建築物運營商能夠識別設施內外的武器和其他威脅,並獲得寶貴的情報以優化運營。欲了解更多信息,請訪問 或者在臉書、推特和領英上連接。
For further information, please contact:
欲了解更多信息,請聯繫:
Xtract One Inquiries: info@xtractone.com,
Xtract One 查詢:info@xtractone.com,
Media Contact: Kristen Aikey, JMG Public Relations, kristen@jmgpr.com, 347-394-8807
媒體聯繫人:克里斯汀·艾基,JMG 公共關係,kristen@jmgpr.com,347-394-8807
Investor Relations: Chris Witty, Darrow Associates, cwitty@darrowir.com, 646-438-9385
投資者關係:Chris Witty,Darrow Associates,cwitty@darrowir.com,646-438-9385
FORWARD LOOKING STATEMENTS
前瞻性陳述
This news release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including, without limitation, statements regarding the anticipated Closing Date, intended use of proceeds from the Offering and Concurrent Private Placement, future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements". Forward-looking statements can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the Company's limited operating history and lack of historical profits; risks related to the Company's business and financial position; fluctuations in the market price of the Company's Common Shares; that the Company may not be able to accurately predict its rate of growth and profitability; the failure of the Company and/or the Agents to satisfy closing conditions to the Offering; whether the Over-Allotment Option will be exercised; whether the Concurrent Private Placement will be completed; the failure of the Company to satisfy certain TSX listing requirements; the failure of the Company to use any of the proceeds received from the Offering or the Concurrent Private Placement in a manner consistent with current expectations; reliance on management; the Company's requirements for additional financing, and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with research and development institutions, clients and suppliers. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although the Company has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. The Company has no intention to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason, except as required by law.
本新聞稿包含適用證券法所指的前瞻性陳述。所有非歷史事實的陳述,包括但不限於有關預期截止日期、本次發行和並行私募收益的預期用途、未來估計、計劃、計劃、預測、預測、目標、假設、預期或對未來業績的信念的陳述,均爲 “前瞻性陳述”。前瞻性陳述可以通過使用 “計劃”、“預期” 或 “不期望”、“預期”、“估計”、“打算”、“預期” 或 “不預期”、“相信” 等詞語或短語或陳述的變體來識別,或者說 “可能”、“可能”、“會”、“可能” 或 “將會” 採取的某些行動、事件或結果的變體已實現。此類前瞻性陳述涉及已知和未知的風險、不確定性和其他因素,這些因素可能導致實際結果、事件或發展與此類前瞻性陳述所表達或暗示的任何未來業績、事件或發展存在重大差異。此類風險和不確定性包括:公司有限的運營歷史和缺乏歷史利潤;與公司業務和財務狀況相關的風險;公司普通股市場價格的波動;公司可能無法準確預測其增長率和盈利能力;公司和/或代理人未能滿足本次發行的成交條件;是否會行使超額配股權;同步私募配售是否會完成; 的失敗公司滿足多倫多證券交易所的某些上市要求;公司未能以符合當前預期的方式使用本次發行或並行私募配售獲得的任何收益;對管理層的依賴;公司對額外融資的要求以及資本市場條件和其他因素對資本可用性的影響;競爭,包括來自更成熟或資金充足的競爭對手的競爭;以及確保和維持企業聯盟和夥伴關係的必要性,包括研究和開發機構, 客戶和供應商.應仔細考慮這些因素,並提醒讀者不要過分依賴此類前瞻性陳述。儘管公司試圖確定可能導致實際行動、事件或結果與前瞻性陳述中描述的重大差異的重要風險因素,但可能還有其他風險因素導致行動、事件或結果與預期、估計或預期的不同。無法保證前瞻性陳述會被證明是準確的,因爲實際結果和未來事件可能與前瞻性陳述中的預期存在重大差異。除非法律要求,否則公司無意更新任何前瞻性陳述,即使由於未來事件、新信息或任何其他原因而獲得新信息。